News & Events

BEAM Alliance
Members
Events

Latest news from BEAM Alliance

16 June 2026 - BEAM ALLIANCE

The G7 presidency presents a unique opportunity for France to make antimicrobial resistance a strategic public health priority

As the G7 meets in Evian (Haute-Savoie) from June 15 to 17, some fifty experts call on France, in an…

21 April 2026 - BEAM ALLIANCE

Integrating Biodefence into the European Competitiveness Fund: A Strategic Imperative

This new paper highlights the urgent need to recognise antimicrobial resistance (AMR) as both a public health threat and a security…

3 March 2026 - BEAM ALLIANCE

BEAM is turning 10!

What a journey since the association was founded in 2016! Since then, awareness of the looming AMR problem has grown,…

11 December 2025 - BEAM ALLIANCE

EU Reaches Landmark Agreement on Pharmaceutical Legislation Revision

After a long night of negotiations, EU co-legislators have reached a long-awaited political agreement on the revision of the Union’s…

20 October 2025 - BEAM ALLIANCE

Defining Eligibility for ‘Priority Antimicrobials’: A Critical Step for Effective PULL Incentives

The General Pharmaceutical Legislation (GPL) should provide broad guidelines for eligibility, leaving the EMA to refine the details. The GPL…

20 October 2025 - BEAM ALLIANCE

Transferable Priority Review Vouchers (TPRVs): Lessons from the US, Implications for EU

If a choice must be made, TEEV offer a clearer, more reliable incentive for SMEs, making them a more appealing…

No results

1 / 10

Latest news of BEAM Members

23 June 2026 - AdjuTec Pharma

AdjuTec Pharma – Phase I Clinical Study Results for APC148 Published

The results demonstrated that APC148 was well tolerated and supported its continued clinical development as a potential solution to combat…

28 May 2026 - Basilea Pharmaceutica International

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Basilea is proud to be developing ceftibuten-ledaborbactam in partnership with BARDA. This funding helps us to further advance this novel…

22 April 2026 - BioVersys

BioVersys completes BV100 Phase 1 clinical trial in China

The completion of this mandatory Phase 1 safety and pharmacokinetic clinical trial in China is crucial in the development of…

16 April 2026 - BioVersys

BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100

Achieving first patient first visit in the RIV-TARGET trial marks a significant milestone for BioVersys in the development of BV100…

15 April 2026 - BioVersys

BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026

To effectively combat antimicrobial resistance, global cross-industry collaboration is of paramount importance. Clinicians, academic researchers, public-private partners, policy makers, and…

13 April 2026 - BioVersys

Data published in Nature Communications highlights unique Mechanism of Action of Alpibectir in combination with Ethionamide (AlpE)

The data provide a compelling scientific foundation in understanding the potential positioning of AlpE in future drug regimens to treat…

No results

1 / 72

Events

10 October 2026

10th Interdisciplinary Course on Antibiotics & Resistance (ICARe)

The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is…

22 September 2026

GAMRIC – Global AMR Innovators Conference

The Global AMR Innovators Conference (GAMRIC) is an event that brings together researchers, academics, and industry professionals from around the…

25 June 2026

Therapeutics and Antimicrobial Resistance (AMR)

The meeting aims to strengthen cross-disciplinary connections, highlight opportunities for impact, and catalyse new initiatives in therapeutics research, outreach and…

28 April 2026

REVIVE Webinar: Natural product-inspired antibiotics: Successes and future prospects

This webinar will explore the successes of natural product-inspired antibiotics and examine their continued potential for the discovery and development…

17 April 2026

ESCMID Global 2026

ESCMID Global is the world’s premier meeting in the fields of Clinical Microbiology and Infectious Diseases.

26 March 2026

REVIVE Webinar: Journal Club: Key findings from recent publications in antimicrobial R&D

In this webinar, individuals who have co-authored publications that have had particular impact in the field of antimicrobial R&D will…

No results

1 / 31

Legal notice | Photo credits

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France